Medivir Ser B Sek5 (CE) News - MVRBF

Medivir AB (MVRBF – Research Report) received a Buy rating and a $3.00 price target from Maxim Group analyst Jason McCarthy on June 17. The...

In a report issued on April 28, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Medivir AB (MVRBF – Research Report), with a...

Medivir AB (MVIR-B.SK), the Swedish pharmaceutical company, Wednesday announced a second quarter net profit of SEK167.4 million, from a loss of...

Swedish pharmaceutical company Medivir AB (MVIR-B.SK) said Wednesday it has renegotiated the terms of its commercial partnership with Meda AB...

GlaxoSmithKline PLC (GSK), a research-based pharmaceutical and healthcare firm, and Medivir (MVIR-B.SK) Wednesday announced an exclusive agreement...

Medivir Ser B Sek5 (CE) (MVRBF) News